JCR Pharmaceuticals Co., Ltd. (JCRRF) Comparison with companies in other sectors?

JCR Pharmaceuticals Co., Ltd. has a share price of 121.86M. You can analyze JCR Pharmaceuticals Co., Ltd. (JCRRF) competitors across different market sectors through stock heatmaps.

What are JCRRF's NET and operating margins?

JCR Pharmaceuticals Co., Ltd. (JCRRF) operating margin is around -0.01, and net profit margin is approximately -0.01 as of the latest reports.

In what way does JCRRF's earnings per share (EPS) trend reflect its financial momentum?

JCR Pharmaceuticals Co., Ltd. (JCRRF) EPS is -0.26 (If EPS value is positive, then “signals consistent profit growth” if Negative then “signals consistent loss”). This metric is also critical in assessing valuation metrics like the P/E ratio for JCR Pharmaceuticals Co., Ltd. is -19.23, and the company’s ability to reinvest or distribute profits.

What does a high ROE mean for JCR Pharmaceuticals Co., Ltd.?

A high ROE suggests efficient use of shareholder equity to generate profit. It often signals strong management and profitability.

How do I know if AAPL is overvalued or undervalued?

Check valuation ratios for JCR Pharmaceuticals Co., Ltd. like P/E which is -220.14, P/B which is 1.69, and PEG which is 0.01. Compare them with sector averages to evaluate if the stock is priced fairly.

JCR Pharmaceuticals Co., Ltd.

JCRRF•PNK

Healthcare

Drug Manufacturers - General

$5.00

$0.00(0.00%)

JCR Pharmaceuticals Co., Ltd. (JCRRF) Fundamental Analysis: Financial Health, Valuation, and Key Ratios

Dive into Apple Inc.’s fundamentals including valuation ratios, profitability, efficiency metrics, and financial health. Use this data to assess long-term investment quality and compare it with sector benchmarks.

EPS (TTM)

$-0.26

P/E Ratio

-19.23

ROE

-0.01%

Net Margin

-0.01%

Key Financial Metrices

Valuation Metrics

4 metrics

Market CapTotal market value of outstanding shares

$609.28M

Shares OutstandingTotal number of shares issued

$121.86M

Book Value/ShareNet worth per share

$457.04

Revenue/ShareAnnual revenue per share

$282.44

Profitability Metrics

6 metrics

EPS (TTM)Earnings per share trailing twelve months

$-0.26

Net MarginNet income as percentage of revenue

-1.23%

Operating MarginOperating income as percentage of revenue

-0.90%

ROEReturn on shareholders' equity

-0.78%

ROAReturn on total assets

-0.42%

ROCEReturn on capital employed

-0.45%

Cash Flow Metrics

3 metrics

Free Cash Flow/ShareCash generated per share after capex

$15.00

Cash/ShareCash and equivalents per share

$146.37

FCF YieldFree cash flow as percentage of market cap

2.002%

Dividend Metrics

2 metrics

Dividend/ShareAnnual dividend payment per share

$20.14

Dividend YieldAnnual dividend as percentage of stock price

2.62%

Financial Ratios Analysis data is not available for JCRRFFinancial Ratios Analysis details for JCRRF are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Sector Benchmarking data is not available for JCRRFSector Benchmarking details for JCRRF are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Understanding Fundamental Analysis for JCR Pharmaceuticals Co., Ltd. Investment Decisions

What is Fundamental Analysis?

Fundamental analysis is a method used to assess the intrinsic value of JCR Pharmaceuticals Co., Ltd.. Using financial reports, management structure, competitive position, and market environment, investors can determine whether the stock is undervalued or overvalued. This analysis helps investors like you make more informed investment decisions, taking into account JCR Pharmaceuticals Co., Ltd.'s unique business strengths and challenges.

Key Financial Metrics for JCR Pharmaceuticals Co., Ltd.

For JCR Pharmaceuticals Co., Ltd., essential financial indicators include EPS -0.26, PE -19.23, and ROE -0.01. These key ratios reveal insights into JCR Pharmaceuticals Co., Ltd.'s profitability, valuation, and operational health. Understanding these metrics enables you to compare JCR Pharmaceuticals Co., Ltd. with its industry peers and decide whether it presents a viable investment opportunity.

Profitability and Operational Efficiency of JCR Pharmaceuticals Co., Ltd.

Metrics like Net Margin -1.23% and ROA -0.42% shed light on how well JCR Pharmaceuticals Co., Ltd. is generating profits. A high profitability ratio often indicates strong management and a solid business model, which are essential for long-term growth. These metrics are crucial in assessing whether JCR Pharmaceuticals Co., Ltd. can sustain its operations and continue growing in the future.

Valuation and Market Position of JCR Pharmaceuticals Co., Ltd.

Using ratios such as P/B Ratio 1.69 and PEG Ratio 0.01, investors can assess whether JCR Pharmaceuticals Co., Ltd. is appropriately valued based on its financials and growth potential. These figures, combined with JCR Pharmaceuticals Co., Ltd.'s market capitalization, give insight into its competitive positioning and investor expectations, helping you make informed decisions on pricing and value.

Financial Health and Risk Assessment for JCR Pharmaceuticals Co., Ltd.

Financial health indicators, such as Debt/Equity Ratio 0.50 and Cash Flow $15.00, provide a snapshot of JCR Pharmaceuticals Co., Ltd.'s ability to meet financial obligations and handle economic setbacks. A company with a strong balance sheet and solid cash flow, like JCR Pharmaceuticals Co., Ltd., is more likely to weather financial storms, making it a safer investment.

Long-Term Investment Strategy for JCR Pharmaceuticals Co., Ltd.

Investing in JCR Pharmaceuticals Co., Ltd. based on fundamental analysis emphasizes long-term business growth rather than short-term market trends. Investors looking at JCR Pharmaceuticals Co., Ltd. focus on its solid financial performance, industry standing, and competitive advantages, all of which suggest sustainable growth and the potential for steady returns over time.

Fundamental Analysis FAQ

;